Abstract:BACKGROUND:The molecular status of epidermal growth factor receptor (EGFR) in esophageal cancer has not been well elucidated. The purpose of the study was to investigate the prevalence of EGFR and K-ras mutation, and EGFR gene copy number status as well as its association with clinicopathologic characteristics, and also to identify the prognostic value of EGFR gene copy number in esophageal cancer. METHODS:EGFR mutation in exon 19/exon 21 and K-ras mutation in codon 12/codon 13 were detected by real-time PCR method, while EGFR gene copy number status was analyzed by fluorescent in situ hybridization (FISH). EGFR gene amplification and high polysomy were defined as high EGFR gene copy number status (FISH-positive), and all else were defined as low EGFR gene copy number status (FISH-negative). The relationship between EGFR gene copy number status and clinicpathologic characteristics was analyzed. Kaplan-Meier method and Cox proportional hazards regression model were employed to evaluate the effects of EGFR gene copy number status on the patients' survival. RESULTS:A total of 57 esophageal squamous cell carcinoma (ESCC) patients and 9 esophageal adenocarcinoma (EADC) patients were enrolled in the study. EGFR mutation was identified in one patient who was diagnosed as ESCC with stage IIIC disease. K-ras mutation was identified in one patient who was diagnosed as EADC. In all, 34 of 66 (51.5%) samples were detected as FISH-positive, which includes 30 ESCC and 4 EADC tumor samples. The correlation analysis showed that FISH-positive was signiﬁcantly associated with the tumor stage (P=0.019) and lymph node metastasis (P=0.005) in esophageal cancer patients, and FISH-positive was also signiﬁcantly associated with the tumor stage (P=0.007) and lymph node metastasis (P=0.008) in ESCC patients. Cox regression analysis showed that high EGFR gene copy number was not a significant predictor of a poor outcome for esophageal cancer patients (P=0.251) or for ESCC patients (P=0.092), but esophageal cancer patients or ESCC patients with low EGFR gene copy number may have longer survival than those with high EGFR gene copy number according to the survival curve trends. CONCLUSIONS:The results indicated that EGFR or K-ras mutation was rare in esophageal cancer, but high EGFR gene copy number is frequent, and correlated with advanced pathologic stage and more number of the metastatic regional lymph nodes, especially in ESCC. In addition, high EGFR gene copy number is likely to have a deleterious effect on prognosis of esophageal cancer patients or ESCC patients, although no statistical significance was reached in the study.

Correlation of epidermal growth factor receptor overexpression with increased epidermal growth factor receptor gene copy number in esophageal squamous cell carcinomas.

Protein Overexpression and Gene Amplification of EGFR in Esophageal Squamous Cell Carcinoma: Relationship Between Malignant Biologic Behavior and EGFR Status Study.

The Prognostic Value of EGFR Overexpression and Amplification in Esophageal Squamous Cell Carcinoma

Epidermal Growth Factor Receptor Protein Overexpression and Gene Amplification Are Associated with Aggressive Biological Behaviors of Esophageal Squamous Cell Carcinoma.

Assessment of epidermal growth factor receptor mutation/copy number and K-ras mutation in esophageal cancer.

Expression of P-EGFR and P-Akt Protein in Esophageal Squamous Cell Carcinoma and Its Prognosis

Prevalence of Gene Amplifications of Sox-2, C-Met, and Fgfr1 in Asian Patients with Esophageal Squamous Cell Carcinoma.

Clinical significance of the expression of EGFR signaling pathway-related proteins in esophageal squamous cell carcinoma

HER-2 gene amplification and protein expression in esophageal squamous cell carcinoma

Overexpression of EGFR in esophageal squamous cell carcinomas – A new biological target in cancer therapy

Expression of EGFR,GST-π and C-erbB-2 in esophageal squamous cell carcinoma and their clinical significance

Pathway Analysis of Differentially Expressed Genes in Human Esophageal Squamous Cell Carcinoma.

Egfr, Her2 and Her3 Expression in Esophageal Primary Tumours and Corresponding Metastases

Expressions of p-EGFR and p-Akt proteins in esophageal squamous cell carcinoma tissue

Prognostic Value of Fgfr1 Overexpression and Amplification in Esophageal Squamous Cell Carcinoma Patients: A Combined Analysis from Tcga Database

Identification of EGFR and KRAS Mutations in Chinese Patients with Esophageal Squamous Cell Carcinoma.

Expression of Nucleostemin, epidermal growth factor and epidermal growth factor receptor in human esophageal squamous cell carcinoma tissues

Relationship Between Epidermal Growth Factor Receptor Gene Mutation and Copy Number in Chinese Patients with Non-Small Cell Lung Cancer

Expression of PC Cell-Derived Growth Factor and Vascular Endothelial Growth Factor in Esophageal Squamous Cell Carcinoma and Their Clinicopathologic Significance.

Clinicopathological and prognostic significance of EGFR over-expression in esophageal squamous cell carcinoma: a meta-analysis.

Clinical Role of Excision Repair Cross-Complementing 1 Gene Expression in Resected Esophageal Squamous Cell Carcinoma: A Meta-Analysis